No abstract

We have developed two parallel series, A and B, of CX3CR1 antagonists for the treatment of multiple sclerosis. By modifying the substituents on the 7-amino-5-thio-thiazolo[4,5-d]pyrimidine core structure, we were able to achieve compounds with high selectivity for CX3CR1 over the closely related CXCR2 receptor. The structure-activity relationships showed that a leucinol moiety attached to the core-structure in the 7-position together with α-methyl branched benzyl derivatives in the 5-position displayed promising affinity, and selectivity as well as physicochemical properties, as exemplified by compounds 18a and 24h. We show the preparation of the first potent and selective orally available CX3CR1 antagonists.

No abstract

No abstract

The fluorescence and triplet state quenching of 7-amino-1,3-naphthalenesulfonic acid by paramagnetic metal ions have been investigated in an aqueous medium. The basic mechanism of the fluorescence quenching involves the static and dynamic electron transfer to the paramagnetic cation. The induced S(1)-->T(1) intersystem crossing at fluorescence quenching of the fluorophore by Cu2+ cation has been found. There is a correlation between triplet state quenching rate constants and values of the efficient paramagnetic susceptibility and spin of the cations. The rate constants for the quenching pathways have been calculated.